Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volunteers at the public lung function event leading the way in taking the active option (left) and Hendrien Witte of Longfonds speaking at the meet the.

Published byTeresa Alcaide Modified over 5 years ago

Similar presentations

Presentation on theme: "Volunteers at the public lung function event leading the way in taking the active option (left) and Hendrien Witte of Longfonds speaking at the meet the."— Presentation transcript:

1 Volunteers at the public lung function event leading the way in taking the active option (left) and Hendrien Witte of Longfonds speaking at the meet the expert evening at the University of Amsterdam’s Academisch Medisch Centrum. Volunteers at the public lung function event leading the way in taking the active option (left) and Hendrien Witte of Longfonds speaking at the meet the expert evening at the University of Amsterdam’s Academisch Medisch Centrum. Dan Smyth et al. Breathe 2015;11: ©2015 by European Respiratory Society

Download ppt "Volunteers at the public lung function event leading the way in taking the active option (left) and Hendrien Witte of Longfonds speaking at the meet the."

Similar presentations

Overall survival from enrolment according to operating rule and scenario of organ scarcity for a) scenario R96 (i.e. 96 organs for 100 virtual patients.

Overall survival from enrolment according to operating rule and scenario of organ scarcity for a) scenario R96 (i.e. 96 organs for 100 virtual patients.
Compliance of the respiratory system (Crs) at baseline and 0 h, 1 h and 2 h following lung volume recruitment. a) Absolute Crs in the respiratory muscle.

Compliance of the respiratory system (Crs) at baseline and 0 h, 1 h and 2 h following lung volume recruitment. a) Absolute Crs in the respiratory muscle.
Flowchart for calculating the relative risk (RR) for cancer X and lung cancer (LC). Flowchart for calculating the relative risk (RR) for cancer X and lung.

Flowchart for calculating the relative risk (RR) for cancer X and lung cancer (LC). Flowchart for calculating the relative risk (RR) for cancer X and lung.
Distribution of forced expiratory volume in 1 s (FEV1) relative to Global Lung Function Initiative reference values (GLI2012) [10] expressed as FEV1 %

Distribution of forced expiratory volume in 1 s (FEV1) relative to Global Lung Function Initiative reference values (GLI2012) [10] expressed as FEV1 %
Axial magnetic resonance (MR) imaging

Axial magnetic resonance (MR) imaging
Axial computed tomography (CT) image and virtual bronchoscopic view

Axial computed tomography (CT) image and virtual bronchoscopic view
Prevalence of true-positive, false-negative and false-positive cases of chronic obstructive pulmonary disease identified with the fixed-limit Global Initiative.

Prevalence of true-positive, false-negative and false-positive cases of chronic obstructive pulmonary disease identified with the fixed-limit Global Initiative.
Integrated positron emission tomography (PET)/computed tomography (CT)

Integrated positron emission tomography (PET)/computed tomography (CT)
Computed tomography simulation of medical thoracoscopy with rigid instruments (right thoracic cavity in left lateral position). Computed tomography simulation.

Computed tomography simulation of medical thoracoscopy with rigid instruments (right thoracic cavity in left lateral position). Computed tomography simulation.
Incidental finding of a nodular lesion in the right upper lobe

Incidental finding of a nodular lesion in the right upper lobe
A) CT scan of patient number 1, before pembrolizumab; b) CT scan of patient number 1, after 11 pembrolizumab infusions; c) CT scan of patient number 1,

A) CT scan of patient number 1, before pembrolizumab; b) CT scan of patient number 1, after 11 pembrolizumab infusions; c) CT scan of patient number 1,
Kaplan–Meier curve for the time until the development of lung cancer in patients with idiopathic pulmonary fibrosis. Kaplan–Meier curve for the time until.

Kaplan–Meier curve for the time until the development of lung cancer in patients with idiopathic pulmonary fibrosis. Kaplan–Meier curve for the time until.
Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.

Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.
Bland–Altman comparison of lung clearance index (LCI) from multiple breath wash-out following open and modified closed circuit wash-in for both healthy.

Bland–Altman comparison of lung clearance index (LCI) from multiple breath wash-out following open and modified closed circuit wash-in for both healthy.
Chest radiograph suggestive of pneumomedia­stinum (air outlining the mediastinal structures) and ­subcutaneous emphysema in the area of the left axilla,

Chest radiograph suggestive of pneumomedia­stinum (air outlining the mediastinal structures) and ­subcutaneous emphysema in the area of the left axilla,
Kaplan–Meier survival curves of all-cause mortality in patients with idiopathic pulmonary fibrosis (IPF). Kaplan–Meier survival curves of all-cause mortality.

Kaplan–Meier survival curves of all-cause mortality in patients with idiopathic pulmonary fibrosis (IPF). Kaplan–Meier survival curves of all-cause mortality.
Predicted values for a, b) FEV1, c, d) FVC and e, f) FEV1/FVC by sex and ethnic group. a, c, e) Males and b, d, f) females. Predicted values for a, b)

Predicted values for a, b) FEV1, c, d) FVC and e, f) FEV1/FVC by sex and ethnic group. a, c, e) Males and b, d, f) females. Predicted values for a, b)
A) Coronal reconstruction of chest CT angiography images showing marked hypodensity of the left upper lobe. b) Coronal reconstruction of maximum intensity.

A) Coronal reconstruction of chest CT angiography images showing marked hypodensity of the left upper lobe. b) Coronal reconstruction of maximum intensity.
Lung volume variations during quiet breathing (grey lines) and vital capacity (blue lines) in an healthy subject (left) and a muscular dystrophy patient.

Lung volume variations during quiet breathing (grey lines) and vital capacity (blue lines) in an healthy subject (left) and a muscular dystrophy patient.
Integrated research framework, bounded by population and ecology of care axes running from highly selected to managed care populations (Y-axis) and from.

Integrated research framework, bounded by population and ecology of care axes running from highly selected to managed care populations (Y-axis) and from.

Similar presentations

Ads by Google